Necrosulfonamide(b)

CAS No. 432531-71-0

Necrosulfonamide(b)( —— )

Catalog No. M20678 CAS No. 432531-71-0

Necrosulfonamide is a novel inhibitor of MLKL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 31 In Stock
5MG 48 In Stock
10MG 67 In Stock
25MG 114 In Stock
50MG 191 In Stock
100MG 286 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Necrosulfonamide(b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Necrosulfonamide is a novel inhibitor of MLKL.
  • Description
    Necrosulfonamide is a novel inhibitor of MLKL.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    MLK
  • Recptor
    necrosis(MLKL)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    432531-71-0
  • Formula Weight
    461.47
  • Molecular Formula
    C18H15N5O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)\C=C\c2ccc(s2)[N+]([O-])=O)cc1
  • Chemical Name
    N-(4-(N-(3-Methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang Y Wang J Wang H et al. Necrosulfonamide Attenuates the Spinal Cord Injury Via Necroptosis Inhibition[J]. World Neurosurgery 2018:S1878875018306569.
molnova catalog
related products
  • GW 806742X

    A small molecule MLKL (Mixed Lineage Kinase Domain-Like) interactor that binds the MLKL pseudokinase domain (Kd=9.3 uM).

  • MLKL-IN-2

    MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.

  • Necrosulfonamide

    A small molecule covalent inhibitor of mixed lineage kinase domain like protein (MLKL) that specifically blocks necrosis downstream of RIP3 activation.